Nature Biotechnology
- 24, 917 - 918 (2006)
doi:10.1038/nbt0806-917
Three barriers to innovative diagnosticsPaul R Billings
Paul R. Billings, MD, PhD, Senior Vice President; Corporate Development, Laboratory Corporation of America Holdings, 128 East Maple Avenue, Burlington, NC, 27215.billinp@labcorp.com
Although technology adoption and remuneration are significant barriers to the development and implementation of innovative diagnostics, health imperialism may be just as important.
|
